DMRA Damora Therapeutics, Inc. - Common Stock
$30,81
Precio · Ago 18, 2026
Fundamentales a fecha de Ago 10, 2026
Rango 52S
$19–$35
75% of range
Calificación del Analista
BUY
16 analysts
Precio Objetivo
$45
+45% upside
P/E (TTM)
—
ROE
-167.0%
Margen de Beneficio Neto
-17981.1%
DMRA Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$30.81
Capitalización Bursátil
—
P/E (TTM)
—
BPA (TTM)
$3.98
Ingresos (TTM)
—
Rendimiento div.
—
ROE
-167.0%
Deuda/Capital
—
Rango 52S
$19 – $35
DMRA Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
Configure
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos y Beneficio Neto
—
BPA
$3.98
2021-12-31
→
2025-12-31
Flujo de caja libre
—
2021-12-31
→
2022-12-31
Márgenes
-17981.1%
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
Métrica
Tendencia a 5 años
DMRA
Mediana de Pares
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
Métrica
Tendencia a 5 años
DMRA
Mediana de Pares
Operating Margin (Margen Operativo)
-18069.6%
—
Net Profit Margin (Margen de Beneficio Neto)
-17981.1%
—
ROA
-151.2%
—
ROE
-167.0%
—
ROIC
-87.8%
—
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
Métrica
Tendencia a 5 años
DMRA
Mediana de Pares
Current Ratio (Ratio corriente)
13.0
—
Quick Ratio (Ratio Rápido)
12.8
—
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Métrica
Tendencia a 5 años
DMRA
Mediana de Pares
Revenue YoY (Ingresos interanuales)
38.3%
—
Revenue CAGR 3Y (Ingresos CAGR 3A)
17.4%
—
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Métrica
Tendencia a 5 años
DMRA
Mediana de Pares
DMRA Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
COMPRA
16 analistas
- Compra fuerte 6 37,5%
- Compra 9 56,2%
- Mantener 1 6,2%
- Venta 0 0,0%
- Venta fuerte 0 0,0%
Precio objetivo a 12 meses
Mediana
$45.00
← Por Debajo de Todos los Objetivos
$30.81
Mín
$40.00
Máx
$51.00
Objetivo mediano
$45.00
+46,1%
Objetivo medio
$44.67
+45,0%
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
1.0%
| Período | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|
| 31 de marzo de 2026 | $-0.62 | $-0.40 | -0.22% |
| 31 de diciembre de 2025 | $2.70 | $-0.11 | 2.8% |
| 31 de diciembre de 2024 | $-5.23 | $-3.03 | -2.2% |
| 30 de septiembre de 2024 | $-3.39 | $-4.18 | 0.79% |
| 30 de junio de 2024 | $-4.00 | $-8.03 | 4.0% |
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| DMRA | — | — | 38.3% | -17981.1% | -167.0% | — |
| STOK | $1.87B | -264.5 | 404.5% | -3.7% | -2.0% | — |
| ZBIO | $1.98B | -4.3 | 100.0% | -3777.4% | -156.8% | — |
| AGIO | $1.59B | -3.8 | 48.0% | -764.0% | -32.2% | — |
| TSHA | $1.57B | -16.2 | 17.3% | -1115.3% | -44.0% | — |
| GENB | — | — | — | — | — | — |
| SRPT | $2.26B | -3.0 | 15.6% | -32.5% | -57.1% | — |
| SNDX | $1.84B | -6.4 | 627.8% | -165.6% | -257.1% | — |
| ANAB | — | -105.4 | 157.0% | — | — | — |
| NTLA | $1.05B | -2.4 | 16.9% | -609.8% | -59.5% | — |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados 13
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| R&D Expense | $27M | $6M | $24M | $48M | $38M | $25M | $20M | |
| SG&A Expense | $10M | $10M | $13M | $13M | $14M | $9M | $2M | |
| Operating Expenses | $211M | $22M | $40M | $61M | $52M | $34M | $39M | |
| Operating Income | $-211M | $-22M | $-40M | $-61M | $-52M | $-34M | $39M | |
| Other Non-op | $1M | $862.0K | $2M | $-417.0K | $475.0K | $-1M | $2M | |
| Pretax Income | $-210M | $-21M | $-38M | $-62M | $-52M | $-35M | $-37M | |
| Income Tax | $50.0K | $41.0K | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-210M | $-21M | $-38M | $-62M | $-52M | $-35M | $-37M | |
| EPS (Basic) | $3.98 | $-18.53 | $-36.08 | $-2.43 | $-2.05 | · | · | |
| EPS (Diluted) | $3.98 | $-18.53 | $-36.08 | $-2.43 | $-2.05 | · | · | |
| Shares (Basic) | 1,363,005 | 1,157,149 | 1,062,873 | 25,409,123 | 25,261,832 | · | · | |
| Shares (Diluted) | 1,363,005 | 1,157,149 | 1,062,873 | 25,409,123 | 25,261,832 | · | · | |
| EBITDA | $-211M | $-22M | $-40M | $-61M | $-52M | $34M | · |
Balance general 21
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $258M | $14M | $21M | $33M | $63M | $164M | $11M | |
| Short-term Investments | · | · | $12M | $27M | $38M | · | · | |
| Prepaid Expense | $3M | $3M | $4M | $4M | $10M | $6M | $5M | |
| Current Assets | $260M | $17M | $37M | $64M | $110M | $169M | $56M | |
| PP&E (Net) | $36.0K | $57.0K | $78.0K | $357.0K | $203.0K | · | · | |
| PP&E (Gross) | $108.0K | $107.0K | $107.0K | $419.0K | $223.0K | · | · | |
| Accum. Depreciation | $72.0K | $50.0K | $29.0K | $62.0K | $20.0K | · | · | |
| Other Non-current Assets | $104.0K | $163.0K | $1M | $2M | $2M | $1M | · | |
| Total Assets | $261M | $17M | $38M | $73M | $122M | $172M | $57M | |
| Accounts Payable | $444.0K | $377.0K | $2M | $3M | $2M | $3M | $3M | |
| Accrued Liabilities | $2M | $820.0K | $4M | $8M | $3M | $3M | $5M | |
| Current Liabilities | $20M | $1M | $6M | $11M | $5M | $6M | $8M | |
| Capital Leases | $53.0K | $61.0K | $66.0K | $328.0K | $448.0K | $541.0K | $211.0K | |
| Other Non-current Liabilities | $81.0K | $43.0K | · | · | · | · | · | |
| Total Liabilities | $20M | $1M | $6M | $11M | $5M | $6M | $8M | |
| Paid-in Capital | $311M | $292M | $288M | $280M | $274M | $269M | $826.0K | |
| Retained Earnings | $-487M | $-278M | $-256M | $-218M | $-156M | $-104M | $-70M | |
| AOCI | $802.0K | $97.0K | $380.0K | $-244.0K | $-320.0K | $674.0K | $-2M | |
| Stockholders' Equity | $240M | $16M | $32M | $62M | $117M | $165M | $-71M | |
| Liabilities + Equity | $261M | $17M | $38M | $73M | $122M | $172M | $57M | |
| Shares Outstanding | 1,597,321 | 1,316,989 | 1,084,509 | 25,652,392 | 25,261,832 | 25,261,832 | 259,966 |
Flujo de Efectivo 10
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $998.0K | $3M | $5M | $6M | $4M | $982.0K | · | |
| Restructuring | · | $968.0K | $3M | · | · | · | · | |
| Operating Cash Flow | $-7M | $-19M | $-37M | $-43M | $-52M | $-38M | $-19M | |
| CapEx | · | · | · | $196.0K | $223.0K | · | · | |
| Investing Cash Flow | $-17M | $12M | $22M | $12M | $-48M | · | $-326.0K | |
| Stock Issued | · | · | $3M | $507.0K | · | · | · | |
| Net Stock Activity | · | · | $3M | $507.0K | · | · | · | |
| Financing Cash Flow | $267M | · | $3M | $507.0K | · | $187M | · | |
| Taxes Paid | $5.0K | · | · | · | · | · | · | |
| Free Cash Flow | · | · | · | $-43M | $-53M | · | · |
Rentabilidad 7
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -18069.6% | -2637.4% | -2362.6% | -8477.4% | -33478.8% | · | · | |
| Net Margin | -17981.1% | -2540.2% | -2270.5% | -8535.2% | -33174.4% | · | · | |
| Pretax Margin | -17976.8% | -2535.3% | -2270.5% | -8535.2% | -33174.4% | · | · | |
| EBITDA Margin | -18069.6% | -2637.4% | -2362.6% | -8477.4% | -33478.8% | · | · | |
| ROA | -151.2% | -77.5% | -68.8% | -63.1% | -35.2% | -30.5% | · | |
| ROE | -167.0% | -116.6% | -110.0% | -91.6% | -41.9% | -94.5% | · | |
| ROIC | -87.8% | -140.9% | -123.4% | -99.1% | -44.5% | 20.3% | · |
Liquidez y Solvencia 2
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 13.0 | 14.1 | 6.3 | 5.8 | 24.2 | 30.4 | · | |
| Quick Ratio | 12.8 | 11.8 | 5.7 | 5.4 | 22.0 | 29.4 | · |
Eficiencia 1
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | · | · |
Tasas de Crecimiento 2
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 38.3% | -50.0% | 133.9% | 362.8% | · | · | · | |
| Revenue CAGR 3Y | 17.4% | 75.5% | · | · | · | · | · |
Valoración (TTM) 2
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1M | $844.0K | $2M | $722.0K | $156.0K | · | · | |
| Net Income TTM | $-210M | $-21M | $-38M | $-62M | $-52M | $-35M | · |
Estado de resultados 13
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $26M | $24M | $23M | $1M | $1M | $678.0K | $1M | $1M | $2M | $2M | $3M | $3M | $8M | $10M | $11M | $10M | |
| SG&A Expense | $9M | $7M | $4M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Operating Expenses | $35M | $31M | $202M | $3M | $3M | $3M | $7M | $4M | $6M | $6M | $7M | $9M | $11M | $13M | $14M | $14M | |
| Operating Income | $-35M | $-31M | $-202M | $-3M | $-3M | $-3M | $-7M | $-4M | $-6M | $-6M | $-7M | $-9M | $-11M | $-13M | $-14M | $-14M | |
| Other Non-op | $4M | $3M | $1M | $23.0K | $-12.0K | $68.0K | $353.0K | $-36.0K | $281.0K | $264.0K | $196.0K | $447.0K | $415.0K | $498.0K | $-544.0K | $-108.0K | |
| Pretax Income | $-31M | $-28M | $-201M | $-3M | $-3M | $-3M | $-7M | $-4M | $-5M | $-5M | $-6M | $-8M | $-11M | · | · | · | |
| Income Tax | $255.0K | $42.0K | $44.0K | $0 | $4.0K | $2.0K | $-8.0K | $7.0K | $42.0K | · | · | · | · | · | · | · | |
| Net Income | $-31M | $-28M | $-201M | $-3M | $-3M | $-3M | $-7M | $-4M | $-5M | $-5M | $-6M | $-8M | $-11M | $-13M | $-14M | $-14M | |
| EPS (Basic) | $-0.39 | $-0.62 | $10.86 | $-2.36 | $-2.60 | $-1.92 | $-5.17 | $-3.39 | $-4.92 | $-5.05 | $-27.66 | $-7.50 | $-0.41 | $-0.51 | $-0.55 | $-0.54 | |
| EPS (Diluted) | $-0.39 | $-0.62 | $10.86 | $-2.36 | $-2.60 | $-1.92 | $-5.17 | $-3.39 | $-4.92 | $-5.05 | $-27.66 | $-7.50 | $-0.41 | $-0.51 | $-0.55 | $-0.54 | |
| Shares (Basic) | 61,117,057 | 34,299,182 | -2,608,598 | 1,327,039 | 1,322,553 | 1,322,011 | -2,156,960 | 1,144,978 | 1,084,622 | 1,084,509 | -52,069,296 | 1,084,191 | 26,375,076 | 25,672,902 | -50,614,809 | 25,491,786 | |
| Shares (Diluted) | 61,117,057 | 34,299,182 | -2,608,598 | 1,327,039 | 1,322,553 | 1,322,011 | -2,156,960 | 1,144,978 | 1,084,622 | 1,084,509 | -52,069,296 | 1,084,191 | 26,375,076 | 25,672,902 | -50,614,809 | 25,491,786 | |
| EBITDA | $-35M | $-31M | · | $-3M | $-3M | $-3M | · | $-4M | $-6M | $-6M | · | $-9M | $-11M | $-13M | · | $-14M |
Balance general 22
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $541M | $533M | $258M | $8M | $10M | $12M | $14M | $20M | $23M | $21M | $21M | $23M | $23M | $25M | $33M | $28M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | $6M | $12M | $21M | $29M | $28M | $27M | $41M | |
| Prepaid Expense | $3M | $3M | $3M | $2M | $3M | $3M | $3M | $2M | $2M | $3M | $4M | $3M | $3M | $4M | $4M | $2M | |
| Current Assets | $544M | $535M | $260M | $10M | $13M | $15M | $17M | $21M | $25M | $31M | $37M | $47M | $55M | $57M | $64M | $71M | |
| PP&E (Net) | · | · | $36.0K | $41.0K | $47.0K | $52.0K | $57.0K | $62.0K | $67.0K | $73.0K | $78.0K | $125.0K | $328.0K | $345.0K | $357.0K | $338.0K | |
| PP&E (Gross) | · | · | $108.0K | $108.0K | $108.0K | $107.0K | $107.0K | $107.0K | $106.0K | $107.0K | $107.0K | $430.0K | $425.0K | $425.0K | $419.0K | $379.0K | |
| Accum. Depreciation | · | · | $72.0K | $67.0K | $61.0K | $55.0K | $50.0K | $45.0K | $39.0K | $34.0K | $29.0K | $305.0K | $97.0K | $80.0K | $62.0K | $41.0K | |
| Other Non-current Assets | $48.0K | $34.0K | $0 | $837.0K | $542.0K | $317.0K | $163.0K | $2M | $2M | $2M | $1M | $2M | $2M | $2M | $2M | $3M | |
| Total Assets | $544M | $535M | $261M | $11M | $14M | $15M | $17M | $23M | $27M | $32M | $38M | $50M | $59M | $65M | $73M | $82M | |
| Accounts Payable | $3M | $819.0K | $444.0K | $520.0K | $756.0K | $354.0K | $377.0K | $503.0K | $724.0K | $2M | $2M | $4M | $6M | $4M | $3M | $2M | |
| Accrued Liabilities | $9M | $6M | $2M | $2M | $2M | $1M | $820.0K | $2M | $3M | $3M | $4M | $8M | $9M | $11M | $8M | $7M | |
| Current Liabilities | $28M | $24M | $20M | $3M | $3M | $2M | $1M | $2M | $4M | $4M | $6M | $13M | $15M | $14M | $11M | $9M | |
| Capital Leases | · | · | $53.0K | $57.0K | $60.0K | $60.0K | $61.0K | · | · | · | $66.0K | $112.0K | $206.0K | $234.0K | $328.0K | $440.0K | |
| Other Non-current Liabilities | $27.0K | $27.0K | $28.0K | $49.0K | $49.0K | $45.0K | $43.0K | · | · | · | · | · | · | · | · | · | |
| Total Liabilities | $28M | $24M | $20M | $3M | $3M | $2M | $1M | $2M | $4M | $4M | $6M | $13M | $15M | $14M | $11M | $9M | |
| Common Stock | $1.0K | $1.0K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Paid-in Capital | $932M | $894M | $311M | $292M | $292M | $292M | $292M | $291M | $290M | $289M | $288M | $287M | $285M | $281M | $280M | $278M | |
| Retained Earnings | $-546M | $-515M | $-487M | $-287M | $-283M | $-280M | $-278M | $-271M | $-267M | $-262M | $-256M | $-250M | $-241M | $-231M | $-218M | $-204M | |
| AOCI | $732.0K | $754.0K | $802.0K | $823.0K | $809.0K | $300.0K | $97.0K | $665.0K | $197.0K | $326.0K | $380.0K | $46.0K | $-137.0K | $-127.0K | $-244.0K | $-2M | |
| Stockholders' Equity | $516M | $512M | $240M | $8M | $11M | $14M | $16M | $21M | $24M | $28M | $32M | $37M | $44M | $50M | $62M | $73M | |
| Liabilities + Equity | $544M | $535M | $261M | $11M | $14M | $15M | $17M | $23M | $27M | $32M | $38M | $50M | $59M | $65M | $73M | $82M | |
| Shares Outstanding | 61,734,601 | 60,303,212 | 1,597,321 | 1,327,212 | 1,324,560 | 1,322,359 | 1,316,989 | 1,253,843 | 27,121,030 | 27,112,697 | 1,084,509 | 27,112,697 | 27,021,899 | 25,673,474 | 25,652,392 | 25,581,029 |
Flujo de Efectivo 9
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $6M | $3M | $483.0K | $164.0K | $172.0K | $179.0K | $308.0K | $681.0K | $891.0K | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| Restructuring | · | · | · | · | · | · | $0 | $0 | $-2M | $3M | · | $3M | · | · | · | · | |
| Operating Cash Flow | $-22M | $-21M | $566.0K | $-3M | $-2M | $-2M | $-5M | $-4M | $-4M | $-6M | $-11M | $-8M | $-8M | $-9M | $-11M | $-10M | |
| CapEx | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $41.0K | $138.0K | |
| Investing Cash Flow | · | · | · | · | · | · | $0 | $0 | $6M | $6M | $10M | $8M | $3M | $1M | $14M | $8M | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | $0 | $171.0K | $3M | $23.0K | $65.0K | $424.0K | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | · | · | $23.0K | · | · | |
| Financing Cash Flow | $30M | $296M | · | · | · | · | · | · | · | · | $0 | $171.0K | $3M | $23.0K | $65.0K | $424.0K | |
| Taxes Paid | · | · | $0 | $0 | $3.0K | $2.0K | · | · | · | · | · | · | · | · | · | · |
Rentabilidad 7
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -862.1% | -1003.6% | · | -7514.3% | -6842.0% | -3512.2% | · | -2630.1% | -2618.3% | -2233.8% | · | -1814.6% | -2524.7% | -3108.8% | · | -6163.8% | |
| Net Margin | -768.0% | -905.0% | · | -7459.5% | -6874.0% | -3423.0% | · | -2659.6% | -2506.1% | -2131.1% | · | -1720.1% | -2430.8% | -2994.0% | · | -6212.7% | |
| Pretax Margin | -761.7% | -903.6% | · | -7459.5% | -6866.0% | -3420.3% | · | -2654.8% | -2486.4% | · | · | · | · | · | · | · | |
| EBITDA Margin | -862.1% | -1003.6% | · | -7514.3% | -6842.0% | -3512.2% | · | -2630.1% | -2618.3% | -2233.8% | · | -1814.6% | -2524.7% | -3108.8% | · | -6163.8% | |
| ROA | -11.2% | -10.1% | · | -18.4% | -16.8% | -10.6% | · | -10.6% | -12.4% | -11.3% | · | -12.3% | -14.2% | -15.0% | · | -12.6% | |
| ROE | -11.8% | -10.6% | · | -21.6% | -19.9% | -12.1% | · | -13.3% | -15.9% | -14.0% | · | -14.8% | -16.7% | -17.1% | · | -13.6% | |
| ROIC | -6.8% | -6.0% | · | -39.4% | -31.3% | -19.0% | · | -18.4% | -23.8% | · | · | · | · | · | · | · |
Liquidez y Solvencia 2
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 19.7 | 22.5 | · | 3.7 | 5.0 | 9.6 | · | 8.7 | 6.8 | 7.1 | · | 3.7 | 3.7 | 4.1 | · | 8.0 | |
| Quick Ratio | 19.6 | 22.4 | · | 2.9 | 3.9 | 7.7 | · | 8.1 | 6.2 | 6.3 | · | 3.5 | 3.5 | 3.8 | · | 7.8 |
Eficiencia 1
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 |
Valoración (TTM) 8
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $7M | $3M | · | $312.0K | $483.0K | $690.0K | · | $1M | $1M | $2M | · | $2M | $1M | $872.0K | · | $473.0K | |
| Net Income TTM | $-66M | $-37M | · | $-13M | $-15M | $-17M | · | $-23M | $-30M | $-37M | · | $-46M | $-54M | $-61M | · | $-60M | |
| Market Cap | $1.61B | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/E | -4.4 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/S | 222.4 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/B | 3.1 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P / Tangible Book | 3.1 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -22.9% | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
Estado de resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Margen Operativo % | -18069.6% | -2637.4% | -2362.6% | -8477.4% | -33478.8% |
| Beneficio neto | $-210M | $-21M | $-38M | $-62M | $-52M |
| EPS Diluido | $3.98 | $-18.53 | $-36.08 | $-2.43 | $-2.05 |
Balance general
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ratio corriente | 13.0 | 14.1 | 6.3 | 5.8 | 24.2 |
| Ratio Rápido | 12.8 | 11.8 | 5.7 | 5.4 | 22.0 |
Flujo de Efectivo
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flujo de caja libre | — | — | — | $-43M | $-53M |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
📊
Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Informantes de la empresa 25 insiders · 11 directivos · 14 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Jennifer Jarrett | President and Chief Executive Officer | 30 de marzo de 2026 A | 500 000 | 0 | 0 | $0 |
| Hans T. Schambye | Chief Executive Officer | 2 de enero de 2026 M | 4 682 | 0 | 1 | $-14 966 |
| Lori Firmani | Chief Financial Officer | 2 de enero de 2026 M | 931 | 0 | 1 | $-2 890 |
| Jonathan Freve | Chief Financial Officer | 3 de enero de 2024 A | 12 000 | 0 | 0 | $0 |
| Sherwin Sattarzadeh | Chief Operating Officer | 5 de enero de 2026 A | 190 376 | 0 | 0 | $0 |
| Anders Pedersen | Chief Operating Officer | 4 de enero de 2023 A | 3 746 | 0 | 0 | $0 |
| Garrett Winslow | General Counsel | 3 de julio de 2026 M | 2 289 | 0 | 2 | $-12 797 |
| Becker L. Hewes | Chief Medical Officer | 5 de enero de 2026 A | 264 629 | 0 | 0 | $0 |
| Matthew Kronmiller | EVP Strategy and CBO | 3 de enero de 2025 A | — | 0 | 0 | $0 |
| Stephanie Oestreich | Chief Business Officer | 4 de enero de 2023 A | — | 0 | 0 | $0 |
| Bertil Lindmark | Chief Medical Officer | 4 de enero de 2023 A | 16 604 | 0 | 0 | $0 |
| Julianne Bruno | Consejero | 23 de marzo de 2026 A | 137 032 | 0 | 0 | $0 |
| Christopher W. Cain | Consejero | 23 de marzo de 2026 A | — | 0 | 0 | $0 |
| Cameron Turtle | Consejero | 23 de marzo de 2026 A | — | 0 | 0 | $0 |
| Michael Landsittel | Consejero | 23 de marzo de 2026 A | — | 0 | 0 | $0 |
| Anne Prener | Consejero | 18 de junio de 2025 A | — | 0 | 0 | $0 |
| Amy B Wechsler | Consejero | 18 de junio de 2025 A | — | 0 | 0 | $0 |
| Jayson Donald Alexander Dallas | Consejero | 18 de junio de 2025 A | — | 0 | 0 | $0 |
| Amit Munshi | Consejero | 18 de junio de 2025 A | 4 793 | 0 | 0 | $0 |
| David Shapiro | Consejero | 18 de junio de 2025 A | — | 0 | 0 | $0 |
| Carl Goldfischer | Consejero | 18 de junio de 2025 A | 19 432 | 0 | 0 | $0 |
| Chau Quang Khuong | Consejero | 14 de junio de 2023 A | 1 031 811 | 0 | 0 | $0 |
| Stephan Christgau | Consejero | 2 de noviembre de 2020 C | 546 136 | 0 | 0 | $0 |
| Novo Holdings A/S | Propietario del 10% | 2 de noviembre de 2020 C | 2 497 791 | 0 | 0 | $0 |
| Andrew Cheng | — | 12 de agosto de 2026 A | — | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Activistas y propietarios del %+ 5 3 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| Fairmount Funds Management LLC, Fairmount Healthcare Fund II L.P., Fairmount Healthcare Co-Invest V L.P., Peter Evan Harwin, Tomas Kiselak ×2 presentaciones | 11 de febrero de 2026 | 19,99% | Enmienda | — | SEC |
| Novo Holdings A/S ×6 presentaciones | 9 de octubre de 2025 | 0,00% | Enmienda | — | SEC |
| OrbiMed Advisors LLC, OrbiMed Advisors Israel II Limited, OrbiMed Israel GP II, L.P., OrbiMed Capital GP VII LLC, OrbiMed Genesis GP LLC, OrbiMed Capital LLC ×7 presentaciones | 18 de septiembre de 2023 | — | Presentación inicial | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Propiedad de ETFs Mantenido por 12 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| IWO · iShares Trust | 0,07% | 331 064 SH | 8 de agosto de 2026 | Diario |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,06% | 39 408 SH | 8 de agosto de 2026 | Diario |
| IWM · iShares Trust | 0,05% | 1 337 645 SH | 8 de agosto de 2026 | Diario |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,04% | 307 241 SH | 8 de agosto de 2026 | Diario |
| IWN · iShares Trust | 0,03% | 152 816 SH | 8 de agosto de 2026 | Diario |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,03% | 14 454 SH | 8 de agosto de 2026 | Diario |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,03% | 2 758 SH | 8 de agosto de 2026 | Diario |
| ISCB · iShares Trust | 0,02% | 2 013 SH | 8 de agosto de 2026 | Diario |
| WSML · iShares Trust | 0,01% | 2 534 SH | 8 de agosto de 2026 | Diario |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 212 600 SH | 8 de agosto de 2026 | Diario |
| IWV · iShares Trust | 0,00% | 14 147 SH | 8 de agosto de 2026 | Diario |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 4 396 SH | 8 de agosto de 2026 | Diario |